Fundraising FoxBrain Trust Accelerator Fund — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
CHASE Pharmaceuticalschasepharmaceuticals.comJan 2016SEC filingmedium confidence
Irvine, CA based Alzheimer's drug company
BiotechWashington, US
Thomas N. Chase(Executive Officer, Director)Douglas Ingram(Executive Officer, Director)John M. Siebert(Executive Officer, Director)Kathleen Clarence-Smith(Executive Officer)
BoardNayan Greg Parekh(Director)
Board seatJohn M. Reher· per SEC Form D · $612.5K raise · filed Feb 2016
Co-investorsAndera PartnersNew Rhein Healthcare Investors, LLC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.